ID
41452
Beskrivning
Study ID: 107671 Clinical Study ID: 107671 Study Title: EGF107671 – A Phase II Study of Lapatinib plus Topotecan or Lapatinib plus Capecitabine in the Treatment of Recurrent Brain Metastases from ErbB2-Positive Breast Cancer Following Cranial Radiotherapy Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00437073 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: N/A Trade Name: capecitabine, topotecan, lapatinib Study Indication: Neoplasms, Breast; Recurrent Brain Metastases
Nyckelord
Versioner (1)
- 2020-10-13 2020-10-13 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
13 oktober 2020
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Lapatinib + Topotecan or + Capecitabine in Recurrent Brain Metastases from Breast Cancer; NCT00437073
Survival Follow-Up
- StudyEvent: ODM
Beskrivning
Survival Follow-Up
Alias
- UMLS CUI-1
- C1522577
- UMLS CUI-2
- C0038952
Beskrivning
Alive (finding)
Datatyp
text
Alias
- UMLS CUI [1]
- C2584946
Beskrivning
Alive (finding), Date last contact
Datatyp
date
Alias
- UMLS CUI [1,1]
- C2584946
- UMLS CUI [1,2]
- C0805839
Beskrivning
Cancer treatment, New
Datatyp
text
Alias
- UMLS CUI [1,1]
- C0920425
- UMLS CUI [1,2]
- C0205314
Beskrivning
Cancer treatment, New, Start Date
Datatyp
date
Alias
- UMLS CUI [1,1]
- C0920425
- UMLS CUI [1,2]
- C0205314
- UMLS CUI [1,3]
- C0808070
Similar models
Survival Follow-Up
- StudyEvent: ODM
C2985720 (UMLS CUI-2)
C2985720 (UMLS CUI [2])
C0038952 (UMLS CUI-2)
C0805839 (UMLS CUI [1,2])
C0205314 (UMLS CUI [1,2])
C0205314 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,3])